Alan H Drummond

Title: Alan H Drummond: Innovator in Hypercholesterolaemia Treatment

Introduction

Alan H Drummond is a notable inventor based in Witney, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hypercholesterolaemia and related conditions. His innovative work has led to the development of valuable compounds that can aid in managing cholesterol levels.

Latest Patents

Drummond holds a patent for "Decaline based HMC-COA reductase inhibitors with two C-6 substituents." This patent includes compounds of general formulae I and II, where R.sup.1, R.sup.2, R.sup.3, R.sup.5, R.sup.6, a, b, c, and d are variables. These compounds are particularly useful in treating hypercholesterolaemia, arteriosclerosis, familial hypercholesterolaemia, and hyperlipidaemia. He has 1 patent to his name.

Career Highlights

Alan H Drummond is associated with British Biotechnology Limited, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has had a profound impact on the treatment options available for patients suffering from cholesterol-related health issues.

Collaborations

Throughout his career, Drummond has collaborated with esteemed colleagues, including Richard S Todd and Christopher Norman Lewis. These partnerships have fostered innovation and have contributed to the success of his projects.

Conclusion

Alan H Drummond is a distinguished inventor whose work in developing treatments for hypercholesterolaemia has made a significant impact in the medical field. His contributions continue to influence the pharmaceutical industry and improve patient outcomes.